FDA blocks imports from India's generic drug giant

WASHINGTON (AP) -- The government is closing U.S. borders to more than 30 generic drugs -- including popular antibiotics and cholesterol medicines -- made by India's drug giant Ranbaxy Laboratories because of poor quality in two of its factories.

The Food and Drug Administration says consumers who already have the drugs shouldn't worry: Repeated testing hasn't found any contamination, and Ranbaxy can continue selling medicines made at any of its other factories.

The showdown instead is over what the FDA says is Ranbaxy's failure to correct significant manufacturing problems that could lead to subpotent drugs, allergic reactions or other problems.

The move also may affect a U.S. program sending AIDS drugs to Africa, as Ranbaxy is a leading supplier.

(Copyright 2008 by The Associated Press. All Rights Reserved.)

You must be logged in to post comments.

Password (case sensitive):
Remember Me:


6450 Papermill Drive Knoxville, TN 37919 Phone - (865) 450-8888; Fax - (865) 450-8869
Copyright © 2016 WVLT-TV Inc. - Designed by Gray Digital Media - Powered by Clickability 28465269 - local8now.com/a?a=28465269
Gray Television, Inc.